Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CCAP vs GAIN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GAIN Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 9–1 Matrix Metrics)

GAIN Overall Winner 6-Pillar Tally: CCAP 2 – 3 GAIN (1 Tie) Matrix Metrics: CCAP 1 – 9 GAIN

As of Nov 16, 2026, Gladstone Investment Corporation (GAIN) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CCAP carries a Unified Composite Score of 19.6/100 (STRONG SELL) at $10.08 (7.0x Forward P/E, 78.4% operating margin), whereas GAIN carries 39.9/100 (SELL) at $14.61 (17.1x Forward P/E, 94.4% operating margin).

  • Defensive Composite Rating Caution: Although GAIN compares more favorably head-to-head, both CCAP (19.6/100 STRONG SELL) and GAIN (39.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3); meanwhile GAIN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CCAP vs GAIN
CCAP NASDAQ
Crescent Capital BDC, Inc. Common stock
Institutional Equity
$10.08
-0.49% 1D
Market Cap $372.1M
TTM Revenue $156M
Forward P/E 7.0x
Beta / 30D Vol 0.44β · 50% Vol
Unified Composite Score
19.6 / 100 STRONG SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 61
RSI-14: 61.3 · SMA20: $9.36 · SMA50: $9.42
GAIN NASDAQ Head-to-Head Winner
Gladstone Investment Corporation
Institutional Equity
$14.61
-1.81% 1D
Market Cap $582.6M
TTM Revenue $104M
Forward P/E 17.1x
Beta / 30D Vol 0.55β · 21% Vol
Unified Composite Score
39.9 / 100 SELL
Tech 46.0 Fund 50.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.6%), weak momentum, RSI 39
RSI-14: 38.7 · SMA20: $14.97 · SMA50: $15.37

6-Pillar Scorecard Institutional Category Breakdown (CCAP 2 – 3 GAIN)

Columns: Metric · CCAP · GAIN
1. Valuation Multiples CCAP
Forward P/E 7.0x 17.1x
Trailing P/E 7.4x 3.8x
PEG Ratio 0.89x 5.41x
EV / Revenue 2.4x 5.6x
2. Growth & Scale GAIN
Revenue Growth (YoY) -15.5% +20.4%
Earnings Growth (YoY) -14.9% +326.5%
TTM Revenue (USD) $156M $104M
Market Cap $372.1M $582.6M
3. Profitability & Quality GAIN
Gross Margin 100.0% 100.0%
Operating Margin 78.4% 94.4%
Net Profit Margin -2.0% 158.9%
Return on Equity (ROE) -0.5% 29.2%
4. Balance Sheet & Cash Flow GAIN
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $19.10 Book/Sh · -0.5% ROE $16.78 Book/Sh · 29.2% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 12.6% (<1st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CCAP
OpEx & R&D Intensity 21.6% of Rev ($34M) 5.6% of Rev ($5.8M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Asset Management Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CCAP (1) vs GAIN (9)
Institutional Metric CCAP GAIN Criterion Row Edge
Market Capitalization
Scale
$372.1M $582.6M Larger Scale GAIN
Trailing P/E Ratio
Valuation
7.4x 3.8x Lower Multiple GAIN
Forward P/E Ratio
Valuation
7.0x 17.1x Lower Multiple CCAP
Revenue Growth (YoY)
Growth
-15.5% +20.4% Higher Growth GAIN
Operating Margin (TTM)
Profitability
78.4% 94.4% Higher Margin GAIN
Net Profit Margin
Profitability
-2.0% 158.9% Higher Margin GAIN
Return on Equity (ROE)
Capital Efficiency
-0.5% 29.2% Higher ROE GAIN
52-Week Range Position
Momentum
25% ($8–$15) 37% ($13–$17) Stronger Trend GAIN
Beta / 30D Volatility
Risk Regime
0.44β · 50% Vol 0.55β · 21% Vol Lower Realized Risk GAIN
Unified Institutional Score
Composite Signal
19.6 / 100 (STRONG SELL) 39.9 / 100 (SELL) Higher Composite GAIN
Trailing 12M Revenue (USD)
Operating Scale
$156M $104M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.89x PEG · 2.4x EV/Rev 5.41x PEG · 5.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($19.10 Book/Sh · -0.5% ROE) N/A ($16.78 Book/Sh · 29.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CCAP +16.18 pp
CCAP: +13.26% · GAIN: -2.92%
3M Horizon CCAP +2.86 pp
CCAP: -6.84% · GAIN: -9.7%
6M Horizon CCAP +1.5 pp
CCAP: -9.03% · GAIN: -10.53%
1Y Horizon GAIN +31.39 pp
CCAP: -25.83% · GAIN: +5.56%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CCAP vs GAIN. Trailing 12-month operating profitability (CCAP 78.4% vs GAIN 94.4%) and valuation multiples (CCAP 7.0x vs GAIN 17.1x Forward P/E) are benchmarked directly in Pillar 4 below.

CCAP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$156M
Gross Margin100.0%
Op. Margin78.4%
ROE / Fwd P/E-0.5% · 7.0x
GAIN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$104M
Gross Margin100.0%
Op. Margin94.4%
ROE / Fwd P/E29.2% · 17.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CCAP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CCAP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GAIN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 12.6%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GAIN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CCAP Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $372.1M market capitalization and 78.4% operating margin.
OpEx & R&D Reinvestment 21.6% of Rev ($34M)
90D Engineering Disclosures 0 Published
GAIN Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $582.6M market capitalization and 94.4% operating margin.
OpEx & R&D Reinvestment 5.6% of Rev ($5.8M)
90D Engineering Disclosures 0 Published

Investor FAQ CCAP vs GAIN Key Questions & Quantitative Answers

As of Nov 16, 2026, Gladstone Investment Corporation (GAIN) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CCAP carries a Unified Composite Score of 19.6/100 (STRONG SELL) at $10.08 (7.0x Forward P/E, 78.4% operating margin), whereas GAIN carries 39.9/100 (SELL) at $14.61 (17.1x Forward P/E, 94.4% operating margin). Defensive Composite Rating Caution: Although GAIN compares more favorably head-to-head, both CCAP (19.6/100 STRONG SELL) and GAIN (39.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3); meanwhile GAIN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GAIN leads the Growth & Scale pillar: CCAP posts -15.5% YoY revenue growth and -14.9% YoY earnings growth on $156M TTM revenue (100.0% gross margin, 78.4% operating margin), compared with GAIN at +20.4% YoY revenue growth and +326.5% YoY earnings growth on $104M TTM revenue (100.0% gross margin, 94.4% operating margin). On trailing 12-month operating scale, CCAP generates $156M in USD-normalized revenue versus $104M for GAIN. In operating R&D and SG&A reinvestment, CCAP deploys 21.6% of Rev ($34M) (0 90-day corporate R&D disclosures) versus 5.6% of Rev ($5.8M) (0 disclosures) for GAIN.

CCAP screens cheaper on headline valuation multiples. CCAP trades at 7.0x Forward P/E, 7.4x Trailing P/E, 0.89x PEG, and 2.4x EV/Revenue (unreported cash flow margin), whereas GAIN trades at 17.1x Forward P/E, 3.8x Trailing P/E, 5.41x PEG, and 5.6x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CCAP (-0.5% ROE) versus GAIN (29.2% ROE) capital efficiency.

In options market volatility and institutional positioning, CCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 50% Vol realized risk). By comparison, GAIN carries 12.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.55β · 21% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.